Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Salute | Prodotti farmaceutici | 138,02 Mrd A$ | 32,7x | 1,59 | 284,99 A$ | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21,4% Rialzo | Fai l’upgrade a Pro+ | |
Resmed DRC | Sydney | Salute | Attrezzature e forniture medicali | 55,39 Mrd A$ | 31,1x | 1,35 | 37,70 A$ | 2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,2% Rialzo | Fai l’upgrade a Pro+ | |
Pro Medicus Ltd | Sydney | Salute | Attrezzature e forniture medicali | 26,90 Mrd A$ | 324,5x | 8,79 | 257,37 A$ | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -28,8% Ribasso | Fai l’upgrade a Pro+ | |
Fisher & Paykel Healthcare Corp | Sydney | Salute | Attrezzature e forniture medicali | 20,15 Mrd A$ | 124,4x | -3,83 | 34,38 A$ | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,3% Rialzo | Fai l’upgrade a Pro+ | |
Cochlear | Sydney | Salute | Attrezzature e forniture medicali | 19,67 Mrd A$ | 56x | 2,87 | 300,09 A$ | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,5% Rialzo | Fai l’upgrade a Pro+ | |
Sonic Health | Sydney | Salute | Fornitori e servizi sanitari | 13,46 Mrd A$ | 26,2x | -0,99 | 28,08 A$ | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,2% Rialzo | Fai l’upgrade a Pro+ | |
Telix Pharma | Sydney | Salute | Ricerca medica e biotecnologica | 8,26 Mrd A$ | 162,5x | 0,82 | 24,73 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,9% Rialzo | Fai l’upgrade a Pro+ | |
Ramsay Health | Sydney | Salute | Fornitori e servizi sanitari | 7,98 Mrd A$ | 9,1x | 0,15 | 34,83 A$ | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,9% Rialzo | Fai l’upgrade a Pro+ | |
Ramsay Health Care Pref | Sydney | Salute | Fornitori e servizi sanitari | 7,98 Mrd A$ | 9,1x | 107,39 A$ | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Ebos | Sydney | Salute | Prodotti farmaceutici | 6,52 Mrd A$ | 23,8x | 3,82 | 33,48 A$ | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,1% Rialzo | Fai l’upgrade a Pro+ | |
Ansell | Sydney | Salute | Attrezzature e forniture medicali | 4,91 Mrd A$ | 36x | -0,81 | 34,02 A$ | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -0,5% Ribasso | Fai l’upgrade a Pro+ | |
Sigma Pharma | Sydney | Salute | Prodotti farmaceutici | 4,65 Mrd A$ | -1.470x | 12,36 | 2,97 A$ | 3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -28,1% Ribasso | Fai l’upgrade a Pro+ | |
Mesoblast | Sydney | Salute | Ricerca medica e biotecnologica | 3,26 Mrd A$ | -20,4x | -1,67 | 2,86 A$ | -6,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -40,7% Ribasso | Fai l’upgrade a Pro+ | |
Summerset Group | Sydney | Salute | Fornitori e servizi sanitari | 2,84 Mrd A$ | 7,7x | 0,15 | 12 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regis Healthcare Ltd | Sydney | Salute | Fornitori e servizi sanitari | 1,92 Mrd A$ | -88,9x | -3,45 | 6,39 A$ | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,1% Rialzo | Fai l’upgrade a Pro+ | |
Neuren Pharma | Sydney | Salute | Prodotti farmaceutici | 1,54 Mrd A$ | 13,1x | 0,12 | 12,04 A$ | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Polynovo | Sydney | Salute | Attrezzature e forniture medicali | 1,41 Mrd A$ | 256,3x | 1,31 | 2,05 A$ | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,4% Rialzo | Fai l’upgrade a Pro+ | |
Clarity Pharmaceuticals | Sydney | Salute | Ricerca medica e biotecnologica | 1,27 Mrd A$ | -44,3x | 0,49 | 4,01 A$ | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Primary Health | Sydney | Salute | Fornitori e servizi sanitari | 1,03 Mrd A$ | -1,5x | 0,03 | 1,43 A$ | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -6% Ribasso | Fai l’upgrade a Pro+ | |
Opthea | Sydney | Salute | Ricerca medica e biotecnologica | 960,25 Mln A$ | -1,4x | 0,37 | 0,78 A$ | 5,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Nanosonics | Sydney | Salute | Attrezzature e forniture medicali | 910,64 Mln A$ | 70,9x | -1,98 | 3,01 A$ | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,6% Rialzo | Fai l’upgrade a Pro+ | |
Botanix Pharma | Sydney | Salute | Prodotti farmaceutici | 817,86 Mln A$ | -50x | 3,59 | 0,45 A$ | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 44,4% Rialzo | Fai l’upgrade a Pro+ | |
Paragon Care Ltd | Sydney | Salute | Attrezzature e forniture medicali | 811,10 Mln A$ | 54,4x | -2,82 | 0,49 A$ | 2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,3% Rialzo | Fai l’upgrade a Pro+ | |
Integral Diagnostics Ltd | Sydney | Salute | Fornitori e servizi sanitari | 687,71 Mln A$ | -11,4x | 0,03 | 2,94 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,8% Rialzo | Fai l’upgrade a Pro+ | |
Australian Clinical Labs | Sydney | Salute | Fornitori e servizi sanitari | 673,16 Mln A$ | 28,2x | -0,86 | 3,39 A$ | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,3% Rialzo | Fai l’upgrade a Pro+ | |
PYC Therapeutics Ltd | Sydney | Salute | Ricerca medica e biotecnologica | 618,26 Mln A$ | -14,1x | 0,45 | 1,33 A$ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Clinuvel Pharmaceuticals Ltd | Sydney | Salute | Prodotti farmaceutici | 588,37 Mln A$ | 16,6x | 0,93 | 11,78 A$ | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Immutep | Sydney | Salute | Ricerca medica e biotecnologica | 506,19 Mln A$ | -9,7x | -0,6 | 0,35 A$ | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ebr Systems DRC | Sydney | Salute | Attrezzature e forniture medicali | 505,90 Mln A$ | -4,4x | 0,69 | 1,39 A$ | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 35,8% Rialzo | Fai l’upgrade a Pro+ | |
Monash IVF Group Ltd | Sydney | Salute | Fornitori e servizi sanitari | 500,68 Mln A$ | -75,9x | 0,58 | 1,28 A$ | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,6% Rialzo | Fai l’upgrade a Pro+ |